Mesa Laboratories (MLAB) Revenue & Revenue Breakdown
Mesa Laboratories Revenue Highlights
Latest Revenue (Q)
$58.17M
Main Segment (Y)
Sterilization and Disinfection Control
Main Geography (Y)
UNITED STATES
Mesa Laboratories Revenue by Period
Mesa Laboratories Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-03-31 | $219.08M | 18.85% |
| 2022-03-31 | $184.34M | 37.63% |
| 2021-03-31 | $133.94M | 13.81% |
| 2020-03-31 | $117.69M | 14.11% |
| 2019-03-31 | $103.14M | 7.23% |
| 2018-03-31 | $96.18M | 2.68% |
| 2017-03-31 | $93.67M | 10.64% |
| 2016-03-31 | $84.66M | 18.69% |
| 2015-03-31 | $71.33M | 35.29% |
| 2014-03-31 | $52.72M | 13.54% |
| 2013-03-31 | $46.44M | 17.21% |
| 2012-03-31 | $39.62M | 20.68% |
| 2011-03-31 | $32.83M | 49.69% |
| 2010-03-31 | $21.93M | 1.82% |
| 2009-03-31 | $21.54M | 10.11% |
| 2008-03-31 | $19.56M | 13.43% |
| 2007-03-31 | $17.24M | 48.86% |
| 2006-03-31 | $11.58M | 15.36% |
| 2005-03-31 | $10.04M | 10.03% |
| 2004-03-31 | $9.13M | 0.49% |
| 2003-03-31 | $9.08M | 0.42% |
| 2002-03-31 | $9.04M | -0.62% |
| 2001-03-31 | $9.10M | 5.14% |
| 2000-03-31 | $8.66M | 6.86% |
| 1999-03-31 | $8.10M | 2.53% |
| 1998-03-31 | $7.90M | 1.28% |
| 1997-03-31 | $7.80M | -3.70% |
| 1996-03-31 | $8.10M | 22.73% |
| 1995-03-31 | $6.60M | 6.45% |
| 1994-03-31 | $6.20M | - |
Mesa Laboratories generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Mesa Laboratories Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $58.17M | -1.25% |
| 2024-03-31 | $58.90M | 10.16% |
| 2023-12-31 | $53.47M | 0.58% |
| 2023-09-30 | $53.16M | 4.98% |
| 2023-06-30 | $50.65M | -8.90% |
| 2023-03-31 | $55.59M | 2.40% |
| 2022-12-31 | $54.29M | -7.60% |
| 2022-09-30 | $58.75M | 16.44% |
| 2022-06-30 | $50.45M | -14.31% |
| 2022-03-31 | $58.88M | 7.65% |
| 2021-12-31 | $54.70M | 52.61% |
| 2021-09-30 | $35.84M | 2.63% |
| 2021-06-30 | $34.92M | -8.02% |
| 2021-03-31 | $37.96M | 11.10% |
| 2020-12-31 | $34.17M | 7.26% |
| 2020-09-30 | $31.86M | 6.41% |
| 2020-06-30 | $29.94M | -12.47% |
| 2020-03-31 | $34.21M | 8.07% |
| 2019-12-31 | $31.66M | 23.96% |
| 2019-09-30 | $25.54M | -2.86% |
| 2019-06-30 | $26.29M | -0.60% |
| 2019-03-31 | $26.45M | -0.88% |
| 2018-12-31 | $26.68M | 7.31% |
| 2018-09-30 | $24.86M | -1.10% |
| 2018-06-30 | $25.14M | -6.47% |
| 2018-03-31 | $26.88M | 13.56% |
| 2017-12-31 | $23.67M | 3.12% |
| 2017-09-30 | $22.95M | 1.24% |
| 2017-06-30 | $22.67M | -6.69% |
| 2017-03-31 | $24.30M | 1.91% |
| 2016-12-31 | $23.84M | -2.32% |
| 2016-09-30 | $24.41M | 15.61% |
| 2016-06-30 | $21.11M | -14.90% |
| 2016-03-31 | $24.81M | 24.60% |
| 2015-12-31 | $19.91M | -8.56% |
| 2015-09-30 | $21.78M | 19.93% |
| 2015-06-30 | $18.16M | -2.17% |
| 2015-03-31 | $18.56M | 4.09% |
| 2014-12-31 | $17.83M | -3.83% |
| 2014-09-30 | $18.54M | 13.05% |
| 2014-06-30 | $16.40M | 4.37% |
| 2014-03-31 | $15.71M | 19.81% |
| 2013-12-31 | $13.12M | 3.47% |
| 2013-09-30 | $12.68M | 13.00% |
| 2013-06-30 | $11.22M | -12.41% |
| 2013-03-31 | $12.81M | 12.74% |
| 2012-12-31 | $11.36M | -2.95% |
| 2012-09-30 | $11.71M | 10.86% |
| 2012-06-30 | $10.56M | -13.29% |
| 2012-03-31 | $12.18M | 31.53% |
| 2011-12-31 | $9.26M | -0.34% |
| 2011-09-30 | $9.29M | 4.53% |
| 2011-06-30 | $8.89M | -10.81% |
| 2011-03-31 | $9.96M | 30.23% |
| 2010-12-31 | $7.65M | -1.32% |
| 2010-09-30 | $7.75M | 4.01% |
| 2010-06-30 | $7.46M | 19.72% |
| 2010-03-31 | $6.23M | 17.09% |
| 2009-12-31 | $5.32M | -1.65% |
| 2009-09-30 | $5.41M | 8.64% |
| 2009-06-30 | $4.98M | -8.93% |
| 2009-03-31 | $5.46M | 2.40% |
| 2008-12-31 | $5.34M | -6.02% |
| 2008-09-30 | $5.68M | 12.37% |
| 2008-06-30 | $5.05M | -12.71% |
| 2008-03-31 | $5.79M | - |
Mesa Laboratories generated $58.17M in revenue during Q1 2025, up -1.25% compared to the previous quarter, and up 104.64% compared to the same period a year ago.
Mesa Laboratories Revenue Breakdown
Mesa Laboratories Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| Clinical Genomics | $52.59M | - | - | - | - |
| Calibration Solutions | $47.76M | - | - | - | - |
| Sterilization and Disinfection Control | $75.12M | - | - | - | - |
| Biopharmaceutical Development | $40.71M | - | - | - | - |
| Service | - | $38.56M | - | - | - |
| Product | - | $180.52M | $149.42M | $107.03M | $93.40M |
Mesa Laboratories's latest annual revenue breakdown by segment (product or service), as of Mar 24: Sterilization and Disinfection Control (34.75%), Clinical Genomics (24.33%), Calibration Solutions (22.09%), and Biopharmaceutical Development (18.83%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Dec 19 | Sep 19 | Jun 19 | Dec 18 | Sep 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Genomics | $11.12M | $12.55M | $15.55M | $13.37M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Biopharmaceutical Development | $12.19M | $9.43M | $9.21M | $9.89M | $10.10M | $8.71M | $9.13M | $5.95M | $5.64M | - | - | - | - | - | - | - | - | - | - | - |
| Calibration Solutions | $12.81M | $12.16M | $11.33M | $11.46M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Sterilization and Disinfection Control | $22.78M | $19.34M | $17.08M | $15.93M | $15.42M | $13.08M | $11.55M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Product | - | - | - | - | $54.29M | $58.75M | $50.45M | $23.97M | $54.70M | $35.84M | $34.92M | - | - | - | - | - | - | - | - | - |
| Continuous Monitoring | - | - | - | - | - | - | - | - | - | - | - | $4.18M | $3.41M | $3.62M | - | - | - | - | - | - |
| Instruments | - | - | - | - | - | - | - | - | - | - | - | $8.26M | $8.97M | $7.56M | $7.68M | $10.01M | $8.96M | $9.54M | $9.34M | $8.70M |
| Cold Chain Monitoring | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.25M | $4.16M | $3.59M | $3.32M | $3.74M | $2.95M |
| Sterilzation and Disinfection Control | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $13.07M | $11.62M | $12.09M | $12.11M | $11.54M | $11.58M |
| Cold Chain Packaging | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $229.00K | $896.00K | $1.32M | $2.05M | $1.63M |
Mesa Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Sterilization and Disinfection Control (38.67%), Calibration Solutions (21.76%), Biopharmaceutical Development (20.69%), and Clinical Genomics (18.88%).
Mesa Laboratories Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| CHINA | $24.93M | $25.80M | - | - | - |
| UNITED STATES | $106.39M | $117.28M | $99.07M | $71.39M | $66.34M |
| Other | $84.86M | $76.00M | - | - | - |
| Non-US | - | - | $85.27M | $62.55M | $51.34M |
| Product | - | - | $149.42M | - | - |
Mesa Laboratories's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (49.21%), Other (39.25%), and CHINA (11.53%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Dec 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHINA | $6.35M | $4.94M | $7.53M | $6.11M | $7.48M | $7.48M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | $27.19M | $25.59M | $27.07M | $26.54M | $28.64M | $30.99M | $29.12M | $30.82M | $30.41M | $19.38M | $18.45M | $19.14M | $18.48M | $11.22M | $16.37M | $18.34M | $17.81M | $15.01M | $15.19M | $17.00M |
| Other | $25.36M | $22.94M | $18.56M | $18.00M | $18.16M | $20.28M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-US | - | - | - | - | - | - | $21.33M | $28.06M | $24.28M | $16.46M | $16.46M | $18.82M | $15.69M | $20.64M | $13.57M | $15.87M | $13.85M | $10.53M | $11.10M | $9.68M |
Mesa Laboratories's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (46.16%), Other (43.06%), and CHINA (10.78%).
Mesa Laboratories Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FTV | Fortive | $6.07B | $1.55B |
| ST | Sensata Technologies | $4.05B | $1.04T |
| VNT | Vontier | $3.10B | $696.40M |
| ITRI | Itron | $2.17B | $609.07M |
| ESE | ESCO | $956.03M | $260.78M |
| NOVT | Novanta | $881.66M | $235.86M |
| BMI | Badger Meter | $703.59M | $216.66M |
| COHR | Coherent | $402.00M | $1.21T |
| VPG | Vishay Precision Group | $355.05M | $77.36M |
| FCUV | Focus Universal | $1.05M | $219.16K |
| MLAB | Mesa Laboratories | - | $58.17M |
MLAB Revenue FAQ
What is Mesa Laboratories’s yearly revenue?
Mesa Laboratories's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $219.08M, representing an increase of 18.85% compared to 2022. MLAB's yearly revenue for 2022 was $184.34M, representing an increase of 37.63% compared to 2021.
What is Mesa Laboratories’s quarterly revenue?
Mesa Laboratories's quarterly revenue for Q1 2025 was $58.17M, a -1.25% decrease from the previous quarter (Q4 2024), and a 14.86% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $58.9M, a 10.16% increase from the previous quarter (Q3 2024), and a 5.96% increase year-over-year (Q4 2023). MLAB's quarterly revenue for Q3 2024 was $53.47M, a 0.58% increase from the previous quarter (Q2 2024), and a -1.50% decrease year-over-year (Q3 2023).
What is Mesa Laboratories’s revenue growth rate?
Mesa Laboratories's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.
What are Mesa Laboratories’s revenue streams?
Mesa Laboratories's revenue streams in r 24 are Clinical Genomics, Calibration Solutions, Sterilization and Disinfection Control, and Biopharmaceutical Development. Clinical Genomics generated $52.59M in revenue, accounting 24.33% of the company's total revenue Calibration Solutions generated $47.76M in revenue, accounting 22.09% of the company's total revenue Sterilization and Disinfection Control generated $75.12M in revenue, accounting 34.75% of the company's total revenue Biopharmaceutical Development generated $40.71M in revenue, accounting 18.83% of the company's total revenue
What is Mesa Laboratories’s main source of revenue?
For the fiscal year ending Mar 24, the largest source of revenue of Mesa Laboratories was Sterilization and Disinfection Control. This segment made a revenue of $75.12M, representing 34.75% of the company's total revenue.